ClinicalTrials.govpublic full text
Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML
acute myeloid leukemia, aml, lovastatin, cytarabine, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 853223
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.